Primary small bowel malignancies: single-center results of three decades.

摘要: We highlight one medical center's experiences with primary malignancies of the small bowel. During a 27-year period, 79 patients were treated for bowel tumors. Of these, 15 (20%) lost to follow-up; thus, 64 reviewed retrospectively emphasis on histological distribution and their topography, perioperative complications, overall survival, prognostic factors. In our 64-patient series, 33 (51.6%) presented adenocarcinoma; 10 (15.5%), lymphoma; 8 (12.1%), leiomyosarcoma; 5 (7.6%), neurogenic tumor; 2 (3%), unclassified carcinoma; other types sarcoma; 1 patient synchronous adenocarcinoma lymphoma. all patients, 30 (46.9%) curatively treated, whereas 34 (53.1%) underwent palliative procedures. Hospital lethality was 9.4% mainly occurred in operated under emergency circumstances. Reoperation rate 29.7%. The observation period lasted at least five years or until death; three alive less than postoperatively. Cumulative five-year survival 22.5% group, 33.3% lymphoma leiomyosarcoma 22.2% uncharacteristic symptoms by suffering from intestinal make early diagnosis difficult. Therefore, especially long-standing diseases, malignancy should be considered. Early surgical treatment lead good prognosis as shown study.